Ironwood Pharmaceuticals, Inc.
IRWD
$4.31
$0.235.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 51.29M | 40.77M | -2.28M | 40.08M | 23.60M |
| Total Depreciation and Amortization | 457.00K | 443.00K | 460.00K | 475.00K | 467.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.25M | 23.71M | 2.93M | 32.24M | 19.55M |
| Change in Net Operating Assets | -12.72M | -59.81M | 73.46M | -25.21M | -58.68M |
| Cash from Operations | 58.28M | 5.12M | 74.58M | 47.58M | -15.07M |
| Capital Expenditure | -- | -- | 1.00K | -2.00K | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 1.00K | -2.00K | -2.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00M | -- | -- | -- | -- |
| Issuance of Common Stock | 303.00K | -- | 122.00K | 0.00 | 88.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -199.70M | -- | 122.00K | 0.00 | 88.00K |
| Foreign Exchange rate Adjustments | 77.00K | -106.00K | 351.00K | -26.00K | -647.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.34M | 5.02M | 75.05M | 47.56M | -15.63M |